Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 23;14(21):5203.
doi: 10.3390/cancers14215203.

Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity

Affiliations

Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity

Massimiliano Berretta et al. Cancers (Basel). .

Abstract

CAM is used by about 40% of cancer patients in Western Countries, with peaks of 80% for breast cancer patients. Cancer patients use CAM to boost immune function, to control cancer symptoms and treatment-related side effects, and to improve health-related quality of life (HR-QoL) and survival. Unfortunately, self-prescription of natural remedies in cancer patients can lead to unexpected toxicities and can reduce the effectiveness of cancer therapy. Although CAM usually refers to all the "natural or organic" products/methods that are generally considered less toxic, there are concerns about drug interactions, especially in patients participating in clinical trials with experimental agents. Despite the claims of the promising and potential benefits made by prescribers, many CAMs lack clear scientific evidence of their safety and efficacy. Given the widespread use of CAM-both clearly declared and overt-in this review, we focused on the most important known data on the risk of interactions between biologics and oncology drugs with the goal of opening up CAM in accordance with the meaning of integrative medicine.

Keywords: alternative; cancer; chemotherapy; complementary; interactions; medicine; synergism.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflict of interest.

Figures

Figure 1
Figure 1
CAM categories.
Figure 2
Figure 2
Possible mechanisms of drug−herb interactions, leading to toxicity development or lack of drug efficacy.
Figure 3
Figure 3
Herbs/nutraceuticals commonly used as CAMs that induce and/or inhibit different CYP subfamilies.
Figure 4
Figure 4
Suitable pharmacovigilance activity via DDI checker programs in cancer patients’ journey.

Similar articles

Cited by

References

    1. Collado-Borrell R., Escudero-Vilaplana V., Romero-Jiménez R., Iglesias-Peinado I., Herranz-Alonso A., Sanjurjo-Sáez M. Oral Antineoplastic Agent Interactions with Medicinal Plants and Food: An Issue to Take into Account. J. Cancer Res. Clin. Oncol. 2016;142:2319–2330. doi: 10.1007/s00432-016-2190-8. - DOI - PMC - PubMed
    1. Berretta M., Franceschi F., Quagliariello V., Montopoli M., Cazzavillan S., Rossi P., Zanello P.P. The Role of Integrative and Complementary Medicine in the Management of Breast Cancer Patients on Behalf of the Integrative Medicine Research Group (IMRG) Eur. Rev. Med. Pharmacol. Sci. 2022;26:947–956. doi: 10.26355/eurrev_202202_28004. - DOI - PubMed
    1. Berretta M., Morra A., Taibi R., Monari F., Maurea N., Ippolito M., Tirelli U., Fiorica F., Montella L., Facchini G., et al. Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Literature. Front. Pharmacol. 2022;13:867907. doi: 10.3389/fphar.2022.867907. - DOI - PMC - PubMed
    1. Complementary and Alternative Medicine (CAM)—NCI. [(accessed on 17 August 2022)]; Available online: https://www.cancer.gov/about-cancer/treatment/cam.
    1. Berretta M., Rinaldi L., Taibi R., Tralongo P., Fulvi A., Montesarchio V., Madeddu G., Magistri P., Bimonte S., Trovò M., et al. Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study. Front. Oncol. 2020;10:594. doi: 10.3389/fonc.2020.00594. - DOI - PMC - PubMed

LinkOut - more resources